Tag:#Gavin Sathianathan

‘Patient Capital’ Backing LSE Debutant As It Eyes A Multi-Billion Pound Prize

LONDON Stock Exchange debutant Oxford Cannabinoid Technologies is aiming to emulate the success of GW Pharmaceuticals. Its founders Gavin Sathianathan and Neil Mahapatra were two...

British Biotech Firm To List on the London Stock Exchange With A Valuation of Over £50m

BIOTECH company Oxford Cannabinoid Technologies to float on the London Stock Exchange in a listing which is set to value it at £51.5m It says...

Setback For Millions As Leading Global Pain Group Baulks At Medical Cannabis

DESPITE the United Nations recently recognising the medical benefits of cannabis, an influential global body says there is insufficient evidence to endorse it for...

NHS Launching Patient Registry To Support Evidence Base For Cannabis Medicines

THE NHS is to launch is first-ever cannabis patient registry in a move which signifies an ambition for the medicines to become more widely-available...

Huge Rise In UK Medical Cannabis Imports As Private Sector Steps-Up To Meet Patient Demand

NEW Government figures show a 900% increase in the number of cannabis medicines notified for import demonstrating the private sector’s growing role in fulfilling...

New Patient Data App Can Help Clear The Hurdles To Medical Cannabis Scripts

SECURING patient-generated data and enabling them to speak the language of the health-care system is at the heart of a ground-breaking development by UK...

Latest news

Thought Leaders Acquisition Of mellow Set To Accelerate Growth Across UK, Europe, And Asia Footprint

THE CBD world is set with a massive shake-up this week as Thought Leaders, the US cannabis & CBD investment company,...
- Advertisement -spot_imgspot_img

Medical Cannabis Cost-Benefit Analysis Set To Be Launched By UK CIC At A Cost of £30,000

THE initial priorities of the UK Cannabis Industry Council have been identified following a special general meeting attended by...

CIC Research Group Looking To Overcome The ‘Scandalous’ Impasse On UK Medical Cannabis Prescribing

Chartered Psychologist and Head of Research at Drug Science, Dr Anne Katrin Schlag, heads up the newly formed Cannabis...

Must read

Medical Cannabis Cost-Benefit Analysis Set To Be Launched By UK CIC At A Cost of £30,000

THE initial priorities of the UK Cannabis Industry Council...

CIC Research Group Looking To Overcome The ‘Scandalous’ Impasse On UK Medical Cannabis Prescribing

Chartered Psychologist and Head of Research at Drug Science,...